Biomarin Pharmaceutical Inc (BMRN) is a publicly traded biotechnology business based in the US which employs around 3,400 staff. BioMarin Pharmaceutical is listed on the NASDAQ and traded in US dollars. Its current price of $80.91 is 7.4% down on its price a month ago ($87.34).
Both exchange rates and share prices fluctuate in real time, so the costs estimated here should be considered as a guide only. They don't factor in spreads, which can be hard to pin down. Always refer to the platform itself for availability and pricing.
Quantity of shares
| Platform | Finder score | Account fee | Min. initial deposit | Trade cost | Link |
|---|---|---|---|---|---|
 |
4.39 ★★★★★ |
£0 | $100 | £780.62 |
Go to siteCapital at risk
|
 |
3.75 ★★★★★ |
0.12% per year | £0 | £778.82 |
Go to siteCapital at risk
|
 |
4.3 ★★★★★ |
£0 | £0 | £780.62 |
Go to siteCapital at risk
|
 |
4.2 ★★★★★ |
£0 | £1 | £796.45 |
Go to siteCapital at risk
|
 |
4.34 ★★★★★ |
0% - 0.25% | £100 | N/A |
Go to siteCapital at risk
|
 |
4.1 ★★★★★ |
£0 | £0 | N/A |
Read reviewCapital at risk
|
 |
4.4 ★★★★★ |
£0 | £0 | £780.62 |
Read reviewCapital at risk
|
Full comparison of share dealing platforms
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Buying shares in just one company is generally considered a riskier bet than investing in a range of investments - AKA a "diversified portfolio". Experts generally recommend holding a mix of investments in specific assets and funds. Funds are ready-made portfolios of multiple companies' shares (potentially including BioMarin Pharmaceutical), and the idea is that drops in the value of one constituent company's share price might be offset by rises in others.
BioMarin Pharmaceutical is a major part of the NASDAQ, so it's included in many global funds and investment trusts, as well as tracker-style exchange traded funds (ETFs).
Only you can make the decision on the time to leap... but here's some supporting information and analysis.
Over the last 12 months, BioMarin Pharmaceutical's shares have ranged in value from as little as $76.02 up to $99.56. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while BioMarin Pharmaceutical's is 0.32. This would suggest that BioMarin Pharmaceutical's shares are less volatile than average (for this exchange).
Historical closes compared with the last close of $80.91
| 1 week (2024-04-18) | -8.71% |
|---|---|
| 1 month (2024-03-27) | -7.36% |
| 3 months (2024-01-25) | -10.96% |
| 6 months (2023-10-26) | 0.30% |
| 1 year (2023-04-27) | -15.75% |
| 2 years (2022-04-27) | -2.09% |
| 3 years (2021-04-27) | 0.56% |
| 5 years (2019-04-25) | -4.91% |
The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.
Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the BioMarin Pharmaceutical P/E ratio, PEG ratio and EBITDA
BioMarin Pharmaceutical's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 76x. In other words, BioMarin Pharmaceutical shares trade at around 76x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the United States stock markets on average as of November 09, 2023 (20.44). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
BioMarin Pharmaceutical's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.7601. A PEG ratio below 1 can be interpreted as meaning the shares are not overvalued given the current rate of growth.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into BioMarin Pharmaceutical's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
BioMarin Pharmaceutical's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $294.8 million (£0.0 million).
The EBITDA is a measure of a BioMarin Pharmaceutical's overall financial performance and is widely used to measure a its profitability.
Sign up for weekly expert share tips
Join 100,000 subscribers who are notified about expert share tips. Plus a chance to win £800!
By signing up you agree to receive emails from Finder and to the privacy policy and terms & conditions.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Ever wondered how to invest in FTAL ETF? Learn more about it now and find out where you can invest in it. Compare ETF brokers to start investing today.
Ever wondered how to invest in FLGB ETF? Learn more about it now and find out where you can invest in it. Compare ETF brokers to start investing today.
Ever wondered how to invest in HUKX ETF? Learn more about it now and find out where you can invest in it. Compare ETF brokers to start investing today.
Thinking about buying shares in Flutter Entertainment? We explain how to do it and compare a range of providers who will give you access to global markets.
Sales of Reckitt Bencksier products like Dettol have risen due to coronavirus. Here’s how you can invest in Dettol, by buying Reckitt Benckiser shares.
Ever wondered how to buy shares in AT&T? We explain how and compare a range of providers that can give you access to many brands, including AT&T.
Ever wondered how to buy shares in Wincanton? We explain how and compare a range of providers that can give you access to many brands, including Wincanton.
Ever wondered how to buy shares in United Utilities? We explain how and compare a range of providers that can give you access to many brands, including United Utilities.
Find out how to buy shares in RELX, see its share prices over the last three months and check out our must-do checklist if you’re looking to invest.
Ever wondered how to buy shares in Reach? We explain how and compare a range of providers that can give you access to many brands, including Reach.